SCHEMBL6026306

SCHEMBL6026306

O=C(Nc1ccc(-c2cnc(-c3ccc(Nc4ccccc4)cc3)[nH]2)cc1)C1CCCCCC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.56
MAPT P10636 3/20 0.55
GAA P10253 2/20 0.55
KMT2A Q03164 2/20 0.55
MEN1 O00255 1/20 0.55
GFER P55789 1/20 0.55
PTPN1 P18031 3/20 0.53
PTPN2 P17706 1/20 0.53
SIRT2 Q8IXJ6 1/20 0.47
ABL1 P00519 1/20 0.47
NR2E3 Q9Y5X4 1/20 0.46
ACVRL1 P37023 1/20 0.46
SCN3A Q9NY46 2/20 0.45
SCN9A Q15858 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
USP2 O75604 1/20 0.45
POLB P06746 1/20 0.45
TSHR P16473 1/20 0.45
HSD17B10 Q99714 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14305032 0.92 PTPN1 (0.62) HPGDMAPTPTPN1PTPN2NR2E3
SCHEMBL6028790 0.92 PTPN1 (0.62) HPGDMAPTPTPN1PTPN2NR2E3
SCHEMBL14311202 0.92 PTPN1 (0.62) HPGDMAPTPTPN1PTPN2NR2E3
SCHEMBL6028360 0.92 PTPN1 (0.62) HPGDMAPTPTPN1PTPN2NR2E3
SCHEMBL6026276 0.90 PTPN1 (0.52) HPGDMAPTGAAKMT2AMEN1
SCHEMBL6026311 0.89 KCNK3 (0.57) HPGDMAPTKMT2AMEN1PTPN1
SCHEMBL6026517 0.88 MEN1 (0.52) KMT2AMEN1PTPN1PTPN2SCN2A
SCHEMBL6027440 0.87 PTPN1 (0.48) HPGDKMT2AMEN1PTPN1PTPN2
SCHEMBL6026099 0.87 NAMPT (0.54) MAPTKMT2AMEN1PTPN1PTPN2
SCHEMBL6025801 0.86 PTPN1 (0.50) HPGDMAPTKMT2APTPN1PTPN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1613310-A1 IMIDAZOLE DERIVATIVES FOR TREATMENT OF ALLERGIC AND HYPERPROLIFERATIVE DISORDERS Avanir Pharmaceuticals (US) 2006-01-11 EP disclosed
WO-2004091610-A1 IMIDAZOLE DERIVATIVES FOR TREATMENT OF ALLERGIC AND HYPERPROLIFERATIVE DISORDERS AVANIR PHARMACEUTICALS (US) 2004-10-28 WO disclosed